NeoGenomics (NASDAQ:NEO – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. Other equities analysts have also recently issued reports about the stock. Needham & Company LLC reduced their price objective on shares of NeoGenomics from $18.00 to […]